Jubilant Pharmova Limited (JUBLPHARMA.NS)
INR 1085.05
(-0.42%)
INR 1085.05
(-0.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 4.86 INR | 227.15% |
| 2022 | -3.83 INR | -114.73% |
| 2021 | 26.01 INR | -50.44% |
| 2020 | 52.48 INR | -6.93% |
| 2019 | 56.39 INR | 56.2% |
| 2018 | 36.10 INR | -12.48% |
| 2017 | 41.25 INR | 11.7% |
| 2016 | 36.93 INR | 47.13% |
| 2015 | 25.10 INR | 791.46% |
| 2014 | -3.63 INR | -152.99% |
| 2013 | 6.85 INR | -28.57% |
| 2012 | 9.59 INR | 953.85% |
| 2011 | 0.91 INR | -93.69% |
| 2010 | 14.42 INR | -49.51% |
| 2009 | 28.56 INR | 56.07% |
| 2008 | 18.30 INR | -30.94% |
| 2007 | 26.50 INR | 74.69% |
| 2006 | 15.17 INR | 68.0% |
| 2005 | 9.03 INR | -4.04% |
| 2004 | 9.41 INR | 48.19% |
| 2003 | 6.35 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 30.51 INR | 929.08% |
| 2024 Q2 | 6.47 INR | -78.79% |
| 2023 Q1 | 0.41 INR | 106.67% |
| 2023 Q3 | 4.19 INR | 6.89% |
| 2023 Q2 | 3.92 INR | 856.1% |
| 2023 Q4 | -3.68 INR | -187.83% |
| 2023 FY | - INR | 227.15% |
| 2022 Q2 | 0.35 INR | -88.18% |
| 2022 FY | - INR | -114.73% |
| 2022 Q4 | -6.15 INR | -527.55% |
| 2022 Q3 | -0.98 INR | -380.0% |
| 2022 Q1 | 2.96 INR | -20.86% |
| 2021 FY | - INR | -50.44% |
| 2021 Q4 | 3.74 INR | 16.88% |
| 2021 Q1 | 10.09 INR | -24.87% |
| 2021 Q3 | 3.20 INR | -64.33% |
| 2021 Q2 | 8.97 INR | -11.1% |
| 2020 Q2 | 14.06 INR | 154.25% |
| 2020 FY | - INR | -6.93% |
| 2020 Q4 | 13.43 INR | -30.99% |
| 2020 Q1 | 5.53 INR | -66.2% |
| 2020 Q3 | 19.46 INR | 38.41% |
| 2019 Q1 | 11.61 INR | 286.06% |
| 2019 FY | - INR | 56.2% |
| 2019 Q2 | 15.66 INR | 34.88% |
| 2019 Q3 | 12.77 INR | -18.45% |
| 2019 Q4 | 16.36 INR | 28.11% |
| 2018 Q1 | 13.00 INR | 30.78% |
| 2018 Q4 | -6.24 INR | -137.28% |
| 2018 FY | - INR | -12.48% |
| 2018 Q3 | 16.74 INR | 24.0% |
| 2018 Q2 | 13.50 INR | 3.85% |
| 2017 Q1 | 9.94 INR | 3.22% |
| 2017 FY | - INR | 11.7% |
| 2017 Q4 | 9.94 INR | -27.13% |
| 2017 Q3 | 13.64 INR | 65.74% |
| 2017 Q2 | 8.23 INR | -17.2% |
| 2016 Q3 | 7.66 INR | -17.55% |
| 2016 Q4 | 9.63 INR | 25.72% |
| 2016 Q2 | 9.29 INR | -3.53% |
| 2016 FY | - INR | 47.13% |
| 2016 Q1 | 9.63 INR | 1237.5% |
| 2015 FY | - INR | 791.46% |
| 2015 Q1 | 8.28 INR | 208.96% |
| 2015 Q2 | 8.11 INR | -2.05% |
| 2015 Q3 | 7.90 INR | -2.59% |
| 2015 Q4 | 0.72 INR | -90.89% |
| 2014 Q3 | -0.70 INR | 88.16% |
| 2014 Q4 | 2.68 INR | 482.86% |
| 2014 Q2 | -5.91 INR | -173.51% |
| 2014 FY | - INR | -152.99% |
| 2014 Q1 | 8.04 INR | 29.68% |
| 2013 FY | - INR | -28.57% |
| 2013 Q4 | 6.20 INR | -31.11% |
| 2013 Q3 | 9.00 INR | 277.87% |
| 2013 Q2 | -5.06 INR | 92.04% |
| 2013 Q1 | -63.56 INR | -3159.49% |
| 2012 Q3 | 1.68 INR | -82.39% |
| 2012 FY | - INR | 953.85% |
| 2012 Q4 | -1.95 INR | -216.07% |
| 2012 Q2 | 9.54 INR | 116.73% |
| 2012 Q1 | -57.02 INR | -1329.07% |
| 2011 FY | - INR | -93.69% |
| 2011 Q3 | -4.92 INR | 0.0% |
| 2011 Q4 | -3.99 INR | 18.9% |
| 2010 FY | - INR | -49.51% |
| 2009 FY | - INR | 56.07% |
| 2008 FY | - INR | -30.94% |
| 2007 FY | - INR | 74.69% |
| 2006 FY | - INR | 68.0% |
| 2005 FY | - INR | -4.04% |
| 2004 FY | - INR | 48.19% |
| 2003 FY | - INR | 0.0% |